| # | Drug | Count |
|---|---|---|
| 0 | TIRZEPATIDE | 2049 |
| 1 | ORAL SEMAGLUTIDE | 885 |
| 2 | SODIUM OXYBATE | 566 |
| 3 | METFORMIN | 524 |
| 4 | METFORMIN ER 500 MG | 467 |
| 5 | METFORMIN ER 750 MG | 467 |
| 6 | INSULIN GLARGINE | 465 |
| 7 | EXENATIDE | 463 |
| 8 | ERGOCALCIFEROL | 446 |
| 9 | LEVOTHYROXINE SODIUM | 370 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SETMELANOTIDE | 17 | 0.0596 |
| 1 | NALTREXONE HYDROCHLORIDE AND BUPROPION HYDROCHLORIDE | 157 | 0.0185 |
| 2 | PSYLLIUM HUSK | 21 | 0.0155 |
| 3 | ERGOCALCIFEROL | 446 | 0.0150 |
| 4 | ZIPRASIDONE | 51 | 0.0142 |
| 5 | PHENTERMINE AND TOPIRAMATE | 81 | 0.0124 |
| 6 | ORAL SEMAGLUTIDE | 885 | 0.0113 |
| 7 | TIRZEPATIDE | 2049 | 0.0113 |
| 8 | CALCIUM, MAGNESIUM, POTASSIUM, AND SODIUM OXYBATES | 101 | 0.0110 |
| 9 | ORLISTAT | 251 | 0.0107 |
| # | Drug class | Count |
|---|---|---|
| 0 | GLP-1 Receptor Agonist [EPC] | 3897 |
| 1 | Glucose-dependent Insulinotropic Polypeptide Receptor Agonist [EPC] | 2049 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 903 |
| 3 | Insulin Analog [EPC] | 780 |
| 4 | Corticosteroid [EPC] | 772 |
| 5 | Atypical Antipsychotic [EPC] | 709 |
| 6 | Benzodiazepine [EPC] | 660 |
| 7 | Proton Pump Inhibitor [EPC] | 474 |
| 8 | Provitamin D2 Compound [EPC] | 446 |
| 9 | Platelet Aggregation Inhibitor [EPC] | 356 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Melanocortin 4 Receptor Agonist [EPC] | 17 | 0.0596 |
| 1 | Adrenocorticotropic Hormone [EPC] | 15 | 0.0168 |
| 2 | Provitamin D2 Compound [EPC] | 446 | 0.0150 |
| 3 | Guanylate Cyclase-C Agonist [EPC] | 30 | 0.0145 |
| 4 | Polymyxin-class Antibacterial [EPC] | 1 | 0.0137 |
| 5 | Interleukin-5 Antagonist [EPC] | 9 | 0.0131 |
| 6 | Lead Chelator [EPC] | 1 | 0.0119 |
| 7 | Intestinal Lipase Inhibitor [EPC] | 251 | 0.0107 |
| 8 | Vesicular Monoamine Transporter 2 Inhibitor [EPC] | 12 | 0.0097 |
| 9 | GLP-1 Receptor Agonist [EPC] | 3897 | 0.0087 |